Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01156727 · ClinicalTrials.gov registry record

Linking National Guard Veterans With Need to Mental Health Care

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
3,015
Enrollment target

NCT01156727: Completed study, sponsored by VA Office of Research and Development.

NCT01156727 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 3,015 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01156727 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
3,015 participants
Enrollment target

Study Summary

This project added an evaluation/research component to an existing peer outreach program, implemented for over 1100 soldiers in the Michigan Army National Guard. The study aims were to: 1) evaluate the implementation of the B2B program to inform ongoing program modifications and facilitate future dissemination efforts, 2) assess whether the B2B program increases mental health and substance use treatment initiation and treatment retention among returning National Guard soldiers, and 3) explore whether the B2B program improves mental health symptoms, deceases hazardous alcohol use, and improves soldier well-being.

Primary Outcome

Hazardous alcohol use was assessed using the AUDIT-C, a 3-item alcohol screen for hazardous drinking and active alcohol use disorders (including alcohol abuse or dependence). In men, a score of 4 or more is considered positive, and in women, a score of 3 or more is considered positive.

Trial Details

FieldValue
Enrollment Target 3,015 participants
Start Date 2010-07-01
Est. Completion 2014-05-30
VA Office of Research and Development

1,668 total trials

What the finished NCT01156727 record still lists

NCT01156727 is an observational study that tracks outcomes without assigning an intervention. Its 3,015 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01156727 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01156727 about?

NCT01156727 is a clinical study titled "Linking National Guard Veterans With Need to Mental Health Care". This project added an evaluation/research component to an existing peer outreach program, implemented for over 1100 soldiers in the Michigan Army National Guard. The study aims were to: 1) evaluate the implementation of the B2B program to inform ongoing program modifications and facilitate future di...

What is the current status of trial NCT01156727?

This trial is currently completed. The enrollment target is 3,015 participants. The study started on 2010-07-01. Estimated completion is 2014-05-30.

Who is sponsoring clinical trial NCT01156727?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01156727, the US trial registry maintained by the National Library of Medicine. NCT01156727 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.